Promoting Wellness Beyond Hormone Therapy, Second Edition: Options for Prostate Cancer Patients
Description:
When a patient is told that his prostate cancer has progressed to a new stage, he has both questions and concerns. Promoting Wellness Beyond Hormone Therapy, Second Edition, is written specifically to answer questions for patients whose prostate cancer is considered hormone-refractory,” meaning that it no longer responds well to hormone therapy. The book provides a wealth of valuable resources for patients, caregivers, and healthcare professionals alike.
Comprehensive information on the many treatment options currently available
The latest updates on an exciting number of therapies undergoing testing now
Suggestions to patients to lessen or eliminate treatment side effects
Question-and-Answer” format gives direct responses to patient queries
Health and wellness tips included throughout the book
Arm yourself with a wealth of new information to discuss with your healthcare provider!
Best prices to buy, sell, or rent ISBN 9781938170393
Frequently Asked Questions about Promoting Wellness Beyond Hormone Therapy, Second Edition: Options for Prostate Cancer Patients
The price for the book starts from $5.06 on Amazon and is available from 25 sellers at the moment.
If you’re interested in selling back the Promoting Wellness Beyond Hormone Therapy, Second Edition: Options for Prostate Cancer Patients book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Promoting Wellness Beyond Hormone Therapy, Second Edition: Options for Prostate Cancer Patients book, the best buyback offer comes from and is $ for the book in good condition.
The Promoting Wellness Beyond Hormone Therapy, Second Edition: Options for Prostate Cancer Patients book is in very low demand now as the rank for the book is 3,990,706 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.